control: Clinical Trials

166 trials of control, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

93 completed, 37 unknown, 14 terminated, 12 recruiting. 166 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4166Completed 93, Unknown 37, Terminated 14, Recruiting 12, Not yet recruiting 4, Withdrawn 3, Active not recruiting 2, Enrolling by invitation 1

Follow control: new trials by email Literature Review of control trials Research Report on control

Trials (filtered) newest first · largest first

All 166 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Geko™ Device in Prevention of Pain and Swelling Following Knee Arthroscopy
Geko, control - Post Operative Swelling
Phase 4Not yet recruitingCedars-Sinai Medical Center462026-12-012026-10-27
Effects of Hypoxia or Caffeine on 4km Time-trial Morning Cycling.
Caffeine (300mg), Placebo (caffeine, paracetamol, cephalexin, or ibuprofen), Control - Caffeine, Hypoxia
Phase 4RecruitingLiverpool John Moores University202026-11-152026-11-13
Improving Morning Strength and Cognitive Performance Using Caffeine or Whole-body Vibration.
Caffeine (300mg), whole-body vibration, Placebo - Vibration Therapy, Caffeine
Phase 4RecruitingLiverpool John Moores University202026-11-012026-11-06
Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors
Desmopressin (DDAVP), Control - Craniopharyngiomas, Pituitary Macroadenoma
Phase 4Enrolling by invitationZhaoyun Zhang1522026-06-022026-07-17
Effect of Noninvasive Ventilation on Physical Activity and Inflammation in COPD Patients
Control, NIMV group - Chronic Obstructive Pulmonary Disease, Hypercapnic
Phase 4UnknownHospital Universitario La Paz502025-12-012023-03-06
Effects of Pre-procedure and Intra-procedure Simethicone and Dicyclomine Administration in Improving Quality of Endoscopic Reterograde Cholangipancreaticography (ERCP)
Preprocedural, Intraprocedural, Control - Motility Disorder of Intestine, Mucosal Clarity
Phase 4CompletedCMH Lahore Medical College and Institute of Dentistry902025-10-012026-04-13
Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries
Enhanced Recovery After Surgery, Control - ERAS
Phase 4RecruitingAga Khan University982025-08-202026-02-17
Post-discharge Malaria Chemoprevention Implementation Trial in Benin
Adherence support strategy A, Adherence support strategy B, Control - Severe Malaria, Severe Anaemia
Phase 4RecruitingInstitut de Recherche Clinique du Benin6482025-07-022026-08-12
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
Magnesium Threonate, Control - Sleep, Knee Osteoarthritis
Phase 4RecruitingUniversity of Miami642025-04-212026-07-09
Coronally Advanced Tunnel Combined With Xenogenic Dermal Matrix and L-PRF
Coronally Advanced Tunel + ADM (Novomatrix®), Coronally Advanced Tunel + ADM (Novomatrix®) + L-PRF - Gingival Recession, Gingival Recession, Localized
Phase 4Not yet recruitingAndres Matteo Pascual La Rocca442025-04-012025-01-28
Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease
l-Histidine, Control - Alzheimer Disease
Phase 4WithdrawnWake Forest University Health Sciences2025-04-012025-04-27
A Multicentre, Randomised, Single-blind, Controlled Protocol to Evaluate the Efficacy of Early Administration of Botulinum Toxin for Primary Midline Closure in Patients With Open Abdomen.
Botulinum Toxin A, CONTROL - Botulinum Toxin Type A, Open Abdomen
Phase 4Not yet recruitingInstituto de Investigación Hospital Universitario La Paz502025-01-012024-08-15
Using Glialia for Treating Persistent Perceptual Postural Dizziness
Glialia, Placebo, Control - Persistent Postural Perceptual Dizziness
Phase 4RecruitingI.R.C.C.S. Fondazione Santa Lucia302024-12-212026-10-05
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
Short duration prophylaxis, Higher intensity and longer duration prophylaxis, Control - Venous Thromboembolism, Venous Thromboses
Phase 4RecruitingLeiden University Medical Center100782024-11-112026-09-08
REstoration of VItamin D in Pulmonary Arterial Hypertension
Calcifediol Oral Capsule, Placebo - Pulmonary Artery Hypertension, Vitamin d Deficiency
Phase 4Not yet recruitingParc de Salut Mar1022024-07-012024-02-14
Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis
Lavender essential oil 10%, diluted in 90% olive oil, Control - Bronchiolitis
Phase 4RecruitingUniversity Hospital, Geneva4002023-12-072025-03-30
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
amoxicillin/clavulanate potassium, Placebo, Budesonide nasal spray - Sinus Infection, Acute Sinusitis
Phase 4RecruitingDaniel Merenstein37202023-11-212026-03-03
Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft
Ibuprofen 600 mg, Placebo, Acetaminophen - Pain, Post Operative, Quality of Life
Phase 4RecruitingMarquette University502023-10-192024-09-27
The Effect of Mediclore as an Anti-adhesion Agent and Safety in Full-endoscopic Spine Surgery: a Preliminary Study
Mediclore, Normal Saline - Lumbar Disc Disease, Epidural Fibrosis
Phase 4UnknownKing Chulalongkorn Memorial Hospital782023-10-012023-09-14
Diode Laser and Photodynamic Therapy Vs. Ciclopirox.
Diode laser combined with photodynamic-red laser therapy by RapidoPodia Laser Diodo®, Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer - Onychomycosis
Phase 4UnknownUniversidad Complutense de Madrid262023-09-012023-05-10

Showing 20 of 166. Sign in to see all of them.

Conditions studied

Diabetes Mellitus (8)  ·  Hemorrhage (6)  ·  Pain, Postoperative (6)  ·  Diabetes Mellitus, Type 2 (4)  ·  Hypertension (4)  ·  Peripheral Arterial Disease (4)  ·  Anemia (3)  ·  Cardiovascular Diseases (3)  ·  Diabetic Foot (3)  ·  Dyslipidemias (3)  ·  Intermittent Claudication (3)  ·  Metabolic Syndrome (3)  ·  Pain (3)  ·  Sinusitis (3)  ·  Acute Kidney Injury (2)

Sponsors

Mahidol University (6)  ·  Seoul National University Hospital (4)  ·  Konkuk University Medical Center (3)  ·  National Cheng-Kung University Hospital (3)  ·  RenJi Hospital (3)  ·  Ain Shams University (2)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Centre for Endocrinology and Reproductive Medicine, Italy (2)  ·  Chulalongkorn University (2)  ·  Healthpoint (2)  ·  Huazhong University of Science and Technology (2)  ·  Leonardo Clavijo (2)  ·  Liverpool John Moores University (2)  ·  Mansoura University (2)  ·  Massachusetts General Hospital (2)

Countries

United States (50)  ·  China (11)  ·  South Korea (10)  ·  Thailand (9)  ·  Egypt (7)  ·  Spain (7)  ·  Brazil (6)  ·  Canada (6)  ·  Italy (6)  ·  Taiwan (5)  ·  Germany (4)  ·  United Kingdom (4)  ·  Australia (3)  ·  Turkey (Türkiye) (3)  ·  Belgium (2)

Top investigators

Ting-Hsing Chao, MD (3)  ·  Herbert B Slade, MD (2)  ·  Leonardo Clavijo, MD, PhD (2)  ·  Sirilak Suksompong, MD (2)  ·  Talerngsak Kanjanabuch, Assist. Prf. (2)  ·  Ahmed R EL-Nahas, A. Professor (1)  ·  Alessandra Sandrini, MD, PhD (1)  ·  Alshaimaa Mohamed, phd (1)  ·  Amin R Javer, MD, FRCSC, FARS (1)  ·  Amin R Javer, MD, FRCSC,FARS (1)  ·  Ana Ciscar, MD (1)  ·  Andrei C Sposito, MD,Phd (1)  ·  Arianna Di Stadio, PhD (1)  ·  Arkom Nongnuch, MD (1)

Results publications

PMID 27207972, PMID 10214567, PMID 10389803, PMID 10671850, PMID 11350323, PMID 11812709, PMID 12190806, PMID 12198045, PMID 12768180, PMID 12803269, PMID 13998, PMID 14557435, PMID 14766688, PMID 14980919, PMID 15235946, PMID 16235676, PMID 16363316, PMID 16731324, PMID 17202008, PMID 17241503, PMID 17261216, PMID 17424883, PMID 17513629, PMID 18044291, PMID 18285392, PMID 18343266, PMID 18433676, PMID 18640467, PMID 19344620, PMID 19509014, PMID 19696679, PMID 20304348, PMID 20381077, PMID 20478449, PMID 20542472, PMID 20825986, PMID 21103330, PMID 21396214, PMID 21453656, PMID 2200299, PMID 23145922, PMID 23162393, PMID 23195688, PMID 23429813, PMID 23705925, PMID 23878437, PMID 23959584, PMID 24145042, PMID 24200273, PMID 24295879

NIH funding

2018 (1), 2019 (1), 2023 (1), 2025 (1), K23MH074540 (1), K24MH122514 (1), R01DA030998 (1), R01DK097554 (1), R01MH035182 (1)